---
title: Infections after chimeric antigen receptor (CAR)-T-cell therapy for hematologic
  malignancies
date: '2023-10-03'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37787373/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20231003180922&v=2.17.9.post6+86293ac
source: heidelberg[Affiliation]
description: 'CONCLUSION: Risk stratification tools are available and may help distinguish
  between infectious and non-infectious causes of fever post-infusion and predict
  severe infections. These tools need prospective validation, and their integration
  in clinical practice needs to be systematically ...'
disable_comments: true
---
CONCLUSION: Risk stratification tools are available and may help distinguish between infectious and non-infectious causes of fever post-infusion and predict severe infections. These tools need prospective validation, and their integration in clinical practice needs to be systematically ...